ACCUDOSE Trademark

Trademark Overview

On Thursday, May 28, 2020, a trademark application was filed for ACCUDOSE with the United States Patent and Trademark Office. The USPTO has given the ACCUDOSE trademark a serial number of 88937671. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 22, 2024. This trademark is owned by NexMed (U.S.A.), Inc.. The ACCUDOSE trademark is filed in the Medical Instrument Products category with the following description:

medical devices, namely, single use dispensers for administering semi-solid pharmaceuticals, sold empty
accudose

General Information

Serial Number88937671
Word MarkACCUDOSE
Filing DateThursday, May 28, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 20, 2021

Trademark Statements

Pseudo MarkACCU DOSE
Goods and Servicesmedical devices, namely, single use dispensers for administering semi-solid pharmaceuticals, sold empty

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, June 17, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNexMed (U.S.A.), Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10022
Party NameNexMed (U.S.A.), Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Monday, June 1, 2020NEW APPLICATION ENTERED
Wednesday, June 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 29, 2020ASSIGNED TO EXAMINER
Thursday, February 25, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, September 5, 2020NON-FINAL ACTION WRITTEN
Saturday, September 5, 2020NON-FINAL ACTION E-MAILED
Saturday, September 5, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 26, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 20, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, February 25, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 31, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 9, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 15, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 9, 2021SOU EXTENSION 1 FILED
Tuesday, November 9, 2021SOU EXTENSION 1 GRANTED
Thursday, June 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 14, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, June 14, 2022SOU EXTENSION 2 FILED
Tuesday, June 14, 2022SOU EXTENSION 2 GRANTED
Monday, April 24, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 14, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 14, 2022SOU EXTENSION 3 FILED
Wednesday, December 14, 2022SOU EXTENSION 3 GRANTED
Friday, December 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 24, 2023SOU EXTENSION 4 FILED
Monday, April 24, 2023SOU EXTENSION 4 GRANTED
Wednesday, April 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 25, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 25, 2023SOU EXTENSION 5 FILED
Tuesday, October 31, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 31, 2023SOU EXTENSION 5 GRANTED
Monday, July 22, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 22, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, November 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

accudose solid pharmaceuticals sold empty semi administering devices namely single dispensers